Nasal Therapy Improves Symptoms, Inflammation in Patients With Chronic Sinusitis
OPN-375 is currently marketed under the brand name Xhance for the treatment of nasal polyps in patients 18 years of age and older.
OPN-375 is currently marketed under the brand name Xhance for the treatment of nasal polyps in patients 18 years of age and older.
OPN-375 is currently marketed under the brand name Xhance for the treatment of nasal polyps in patients 18 years of age and older.
Multivariate analyses showed that the use of narcotic medications was significantly associated with greater 30-day postoperative complications.
Online information needed to warn those with history of sinus, pituitary surgery to avoid nasopharyngeal swab testing, use alternative testing
Sinuva can be implanted during a routine physician visit under local or topical anesthesia.
Duration of outpatient antibiotic therapy for acute sinusitis often exceeds guidelines recommendations.